Copenhagen V
Denmark
46
2023-01-26
38
2023-03-21
These are the the leading inventors for applications assigned to GENMAB A/S:
GENMAB A/S based in Copenhagen V, DK has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
METHODS OF TREATING CANCER WITH A COMBINATION OF AN ANTI-PD-1 ANTIBODY AND AN ANTI-TISSUE FACTOR ANTIBODY-DRUG CONJUGATE
#2 | 2022-12-08METHODS OF TREATING CANCER WITH A COMBINATION OF A PLATINUM-BASED AGENT AND AN ANTI-TISSUE FACTOR ANTIBODY-DRUG CONJUGATE
#3 | 2022-05-12 ✅ Patent 11,608,383 granted on 2023-03-21Bispecific antibody against CD3 and CD20 in combination therapy for treating follicular lymphoma
#4 | 2022-04-14 ✅ Patent 11,548,952 granted on 2023-01-10Bispecific antibody against CD3 and CD20 in combination therapy for treating diffuse large B-cell lymphoma
#5 | 2022-04-14 ✅ Patent 11,535,679 granted on 2022-12-27Bispecific antibody against CD3 and CD20 in combination therapy for treating follicular lymphoma
#6 | 2022-03-24 ✅ Patent 12,324,841 granted on 2025-06-10METHODS OF TREATING CANCER WITH A COMBINATION OF AN ANTI-PD-1 ANTIBODY AND AN ANTI-TISSUE FACTOR ANTIBODY-DRUG CONJUGATE
#7 | 2022-02-17 ✅ Patent 11,261,254 granted on 2022-03-01Antibodies
#8 | 2021-12-30METHODS OF TREATING CANCER WITH A COMBINATION OF AN ANTI-VEGF ANTIBODY AND AN ANTI-TISSUE FACTOR ANTIBODY-DRUG CONJUGATE
#9 | 2021-10-14 ✅ Patent 11,440,966 granted on 2022-09-13Multispecific antibodies against CD40 and CD137
#10 | 2021-07-29 ✅ Patent 11,130,819 granted on 2021-09-28Antibodies
#11 | 2021-06-10HUMAN ANTIBODIES AGAINST TISSUE FACTOR AND METHODS OF USE THEREOF
#12 | 2021-05-27ANTIBODY VARIANTS HAVING MODIFICATIONS IN THE CONSTANT REGION
#13 | 2021-03-11 ✅ Patent 11,008,399 granted on 2021-05-18Antibodies
#14 | 2021-03-04STABLE IgG4 ANTIBODIES
#15 | 2020-10-22 ✅ Patent 11,485,796 granted on 2022-11-01Inert format
#16 | 2020-10-08Human Monoclonal Antibodies Against CD20
#17 | 2020-08-27 ✅ Patent 11,578,141 granted on 2023-02-14Bispecific antibodies against HER2 and CD3
#18 | 2020-06-25 ✅ Patent 11,613,575 granted on 2023-03-28Humanized or chimeric CD3 antibodies
#19 | 2020-05-28 ✅ Patent 10,968,280 granted on 2021-04-06Binding agents binding to PD-L1 and CD137 and use thereof
#20 | 2020-03-12 ✅ Patent 11,512,140 granted on 2022-11-29Monoclonal antibodies against c-Met
#21 | 2020-02-27 ✅ Patent 11,091,557 granted on 2021-08-17Methods of producing multispecific antibodies against CD40 and CD137
#22 | 2020-02-13 ✅ Patent 11,492,371 granted on 2022-11-08Production of heterodimeric proteins
#23 | 2019-09-12 ✅ Patent 10,765,743 granted on 2020-09-08Antibodies binding AXL
#24 | 2019-05-30 ✅ Patent 10,500,276 granted on 2019-12-10Antibodies binding AXL
#25 | 2019-01-31DOSING REGIMENS FOR ANTI-TF-ANTIBODY DRUG-CONJUGATES
#26 | 2018-10-18 ✅ Patent 11,230,604 granted on 2022-01-25Antibodies against human CD38
#27 | 2018-08-02 ✅ Patent 11,091,553 granted on 2021-08-17Monoclonal antibodies against HER2
#28 | 2018-08-02 ✅ Patent 10,201,607 granted on 2019-02-12Antibodies binding AXL
#29 | 2018-07-12 ✅ Patent 11,046,771 granted on 2021-06-29Monoclonal antibodies against HER2
#30 | 2018-01-25 ✅ Patent 10,793,640 granted on 2020-10-06Monoclonal antibodies against HER2 epitope
#31 | 2017-12-14 ✅ Patent 10,544,220 granted on 2020-01-28Bispecific antibodies against CD3 and CD20
#32 | 2017-11-16 ✅ Patent 10,865,253 granted on 2020-12-15Rodent bispecific heterodimeric proteins
#33 | 2017-08-24 ✅ Patent 10,703,818 granted on 2020-07-07Human monoclonal antibodies against CD25
#34 | 2017-08-17 ✅ Patent 10,597,464 granted on 2020-03-24Heterodimeric antibody Fc-containing proteins and methods for production thereof
#35 | 2017-06-08 ✅ Patent 10,512,688 granted on 2019-12-24Antibodies binding AXL
#36 | 2017-02-09 ✅ Patent 10,351,629 granted on 2019-07-16Recombinant IgG4 monovalent antibodies
#37 | 2017-02-02 ✅ Patent 10,752,695 granted on 2020-08-25Stable IgG4 antibodies
#38 | 2016-11-17 ✅ Patent 10,407,501 granted on 2019-09-10Humanized or chimeric CD3 antibodies
#39 | 2016-09-29 ✅ Patent 10,617,764 granted on 2020-04-14Lyophilized anti-tissue factor antibody-drug conjugates
#40 | 2016-08-18 ✅ Patent 9,944,711 granted on 2018-04-17Antibodies against human CD38
#41 | 2016-06-16 ✅ Patent 10,465,006 granted on 2019-11-05Humanized or chimeric CD3 antibodies
#42 | 2016-06-09 ✅ Patent 10,906,991 granted on 2021-02-02Bispecific antibodies and methods for production thereof
#43 | 2015-12-31 ✅ Patent 10,000,570 granted on 2018-06-19Antibody variants having modifications in the constant region
#44 | 2015-11-26 ✅ Patent 10,590,206 granted on 2020-03-17Inert format
#45 | 2013-07-25 ✅ Patent 9,862,769 granted on 2018-01-09Monoclonal antibodies against HER2
#46 | 2009-09-10 ✅ Patent 10,155,816 granted on 2018-12-18Recombinant monovalent antibodies and methods for production thereof
Also check out GENMAB A/S's (Copenhagen V, Denmark) applicant profile with 43 patent applications submitted.
128979 ⎘